首页> 外文期刊>Antiviral therapy >Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures.
【24h】

Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures.

机译:抗正痘病毒化合物ST-246在细胞单层和器官型筏培养中对牛痘,牛痘和骆驼痘病毒的活性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: The potential use of variola virus as a biological weapon has renewed efforts in the development of antiviral agents against orthopoxviruses. ST-246 [4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-di oxo-4,6-ethenocycloprop [f]isoindol-2(1 H)-yl)-benzamide] is an anti-orthopoxvirus compound active against several orthopoxviruses including vaccinia virus (VV), cowpox virus (CPV), camelpox virus (CMLV), ectromelia virus (ECTV) and variola virus in cell culture. The compound has been shown to inhibit the release of extracellular virus by targeting the F13L W protein and to protect mice from W, CPV and ECTV orthopoxvirus-induced disease. METHODS: The antiviral activity of ST-246 was assessed against extracellular and intracellular W, CPV and CMLV production in human embryonic lung (HEL) fibroblasts and primary human keratinocyte (PHK) cell monolayers, as well as in three-dimensional raft cultures. RESULTS: ST-246 inhibited preferentially the production of extracellular virus compared with intracellular virus production in HEL and PHK cells (for W) and in PHK cells (for CMLV). In organotypic epithelial raft cultures, ST-246 at 20 microg/ml inhibited extracellular W and CMLV production by 6 logs, whereas intracellular virus yield was reduced by 2 logs. In the case of CPV, both extracellular and intracellular virus production were completely inhibited by ST-246 at 20 microg/ml. Histological sections of the infected rafts, treated with increasing amounts of drug, confirmed the antiviral activity of ST-246: the epithelium was protected and there was no evidence of viral infection. Electron microscopic examination confirmed the absence of intracellular enveloped virus forms in W-, CPV- and CMLV-infected cells treated with 10 microg/ml of ST-246. CONCLUSIONS: These data indicate that ST-246 is a potent anti-orthopoxvirus compound; the mode of inhibition is dependent on the virus and cell type.
机译:背景:天花病毒作为生物武器的潜在用途已在开发针对正痘病毒的抗病毒药物方面重新进行了努力。 ST-246 [4-三氟甲基-N-(3,3a,4,4a,5,5a,6,6a-八氢-1,3-二氧代-4,6-乙炔环丙[f]异吲哚-2(1 H )-基)-苯甲酰胺]是一种抗正痘病毒化合物,在细胞培养中对多种正痘病毒具有活性,其中包括牛痘病毒(VV),牛痘病毒(CPV),骆驼痘病毒(CMLV),念珠菌病毒(ECTV)和天花病毒。该化合物已被证明可通过靶向F13L W蛋白来抑制细胞外病毒的释放,并保护小鼠免受W,CPV和ECTV正痘病毒引起的疾病的侵害。方法:评估了ST-246对人胚肺(HEL)成纤维细胞和原代人角质形成细胞(PHK)细胞单层以及三维筏培养中细胞外和细胞内W,CPV和CMLV产生的抗病毒活性。结果:与HEL和PHK细胞(用于W)和PHK细胞(用于CMLV)中的细胞内病毒产生相比,ST-246优先抑制细胞外病毒的产生。在器官型上皮筏培养物中,浓度为20 microg / ml的ST-246抑制细胞外W和CMLV的产量达6个对数,而细胞内病毒的产量则减少2个对数。对于CPV,ST-246以20微克/毫升的浓度完全抑制细胞外和细胞内病毒的产生。用越来越多的药物治疗感染的木筏的组织学切片,证实了ST-246的抗病毒活性:上皮受到保护,没有病毒感染的迹象。电子显微镜检查证实,用10μg/ ml ST-246处理的W,CPV和CMLV感染的细胞中不存在细胞内包膜病毒形式。结论:这些数据表明ST-246是一种有效的抗正痘病毒化合物。抑制方式取决于病毒和细胞类型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号